

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 9.15199141 |
| 2 | cellular response to ATP (GO:0071318) | 7.47726662 |
| 3 | DNA strand renaturation (GO:0000733) | 7.42926193 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 6.97177803 |
| 5 | negative regulation of cell aging (GO:0090344) | 6.69822687 |
| 6 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 6.61101949 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 6.46358536 |
| 8 | meiotic chromosome segregation (GO:0045132) | 6.38075495 |
| 9 | rRNA methylation (GO:0031167) | 5.99601020 |
| 10 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.71321963 |
| 11 | rRNA modification (GO:0000154) | 5.58743921 |
| 12 | lens fiber cell differentiation (GO:0070306) | 5.29764562 |
| 13 | UV protection (GO:0009650) | 5.14108098 |
| 14 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.13665905 |
| 15 | purine ribonucleotide transport (GO:0015868) | 4.96611191 |
| 16 | adenine nucleotide transport (GO:0051503) | 4.69919954 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.63371947 |
| 18 | mitotic cell cycle arrest (GO:0071850) | 4.60961259 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.59186081 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 4.59186081 |
| 21 | mannose metabolic process (GO:0006013) | 4.52010471 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.49425840 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 4.49425840 |
| 24 | purinergic receptor signaling pathway (GO:0035587) | 4.44667985 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.43198776 |
| 26 | positive regulation of protein kinase C signaling (GO:0090037) | 4.41293008 |
| 27 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.37453487 |
| 28 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.35517568 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35217175 |
| 30 | nucleoside transmembrane transport (GO:1901642) | 4.27943910 |
| 31 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.25743453 |
| 32 | response to ATP (GO:0033198) | 4.19001520 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 4.09227796 |
| 34 | cysteine metabolic process (GO:0006534) | 4.03884463 |
| 35 | nucleotide transmembrane transport (GO:1901679) | 4.03833367 |
| 36 | glyoxylate metabolic process (GO:0046487) | 3.90074727 |
| 37 | sensory perception of taste (GO:0050909) | 3.89058624 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86955814 |
| 39 | folic acid metabolic process (GO:0046655) | 3.85101972 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 3.84916806 |
| 41 | sphingomyelin metabolic process (GO:0006684) | 3.84501094 |
| 42 | tRNA modification (GO:0006400) | 3.83054078 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76595353 |
| 44 | protein carboxylation (GO:0018214) | 3.76595353 |
| 45 | positive regulation of heat generation (GO:0031652) | 3.76063567 |
| 46 | sphingosine metabolic process (GO:0006670) | 3.74890238 |
| 47 | DNA replication checkpoint (GO:0000076) | 3.70902668 |
| 48 | transepithelial transport (GO:0070633) | 3.70359216 |
| 49 | purine nucleotide transport (GO:0015865) | 3.63136899 |
| 50 | pseudouridine synthesis (GO:0001522) | 3.60025056 |
| 51 | aldehyde catabolic process (GO:0046185) | 3.57174363 |
| 52 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57015740 |
| 53 | regulation of cell aging (GO:0090342) | 3.53130942 |
| 54 | drug transmembrane transport (GO:0006855) | 3.48567802 |
| 55 | drug transport (GO:0015893) | 3.45373086 |
| 56 | protein insertion into membrane (GO:0051205) | 3.45098588 |
| 57 | iron-sulfur cluster assembly (GO:0016226) | 3.44853923 |
| 58 | metallo-sulfur cluster assembly (GO:0031163) | 3.44853923 |
| 59 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.42363839 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.40772969 |
| 61 | cellular glucuronidation (GO:0052695) | 3.40559268 |
| 62 | tryptophan catabolic process (GO:0006569) | 3.39671698 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 3.39671698 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 3.39671698 |
| 65 | bile acid biosynthetic process (GO:0006699) | 3.39470853 |
| 66 | negative regulation of interleukin-8 production (GO:0032717) | 3.37890880 |
| 67 | diol metabolic process (GO:0034311) | 3.36623437 |
| 68 | primary alcohol catabolic process (GO:0034310) | 3.35517624 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.34928701 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 3.34427656 |
| 71 | lysine metabolic process (GO:0006553) | 3.33206526 |
| 72 | lysine catabolic process (GO:0006554) | 3.33206526 |
| 73 | tryptophan metabolic process (GO:0006568) | 3.30301357 |
| 74 | urate metabolic process (GO:0046415) | 3.28908382 |
| 75 | nucleoside transport (GO:0015858) | 3.28229602 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.27955818 |
| 77 | glucuronate metabolic process (GO:0019585) | 3.27955818 |
| 78 | base-excision repair, AP site formation (GO:0006285) | 3.24693831 |
| 79 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.24591325 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.24286478 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 3.20992505 |
| 82 | Golgi transport vesicle coating (GO:0048200) | 3.20992505 |
| 83 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.20704991 |
| 84 | melanin biosynthetic process (GO:0042438) | 3.20620997 |
| 85 | peptidyl-histidine modification (GO:0018202) | 3.19398026 |
| 86 | histone phosphorylation (GO:0016572) | 3.18253737 |
| 87 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.18078003 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.18070805 |
| 89 | serine family amino acid catabolic process (GO:0009071) | 3.17643532 |
| 90 | complement activation, alternative pathway (GO:0006957) | 3.17506553 |
| 91 | granulocyte differentiation (GO:0030851) | 3.16668143 |
| 92 | proline biosynthetic process (GO:0006561) | 3.15959569 |
| 93 | folic acid transport (GO:0015884) | 3.14335386 |
| 94 | pyrimidine nucleoside salvage (GO:0043097) | 3.14093072 |
| 95 | pyrimidine-containing compound salvage (GO:0008655) | 3.14093072 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.13725542 |
| 97 | drug catabolic process (GO:0042737) | 3.13216162 |
| 98 | nucleotide salvage (GO:0043173) | 3.12906520 |
| 99 | ethanol metabolic process (GO:0006067) | 3.08286379 |
| 100 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.07843015 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05180920 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05180920 |
| 103 | valine metabolic process (GO:0006573) | 3.04889166 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 3.04839739 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.04055885 |
| 106 | iron coordination entity transport (GO:1901678) | 3.03452222 |
| 107 | ethanol oxidation (GO:0006069) | 3.02538125 |
| 108 | modulation by virus of host process (GO:0019054) | 3.01050351 |
| 109 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.00855092 |
| 110 | interferon-gamma production (GO:0032609) | 2.98488077 |
| 111 | carnitine metabolic process (GO:0009437) | 2.96497333 |
| 112 | urea metabolic process (GO:0019627) | 2.94979525 |
| 113 | urea cycle (GO:0000050) | 2.94979525 |
| 114 | homocysteine metabolic process (GO:0050667) | 2.94978728 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.94749949 |
| 116 | detection of light stimulus involved in visual perception (GO:0050908) | 2.93516534 |
| 117 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.93516534 |
| 118 | regulation of protein activation cascade (GO:2000257) | 2.93364767 |
| 119 | fatty acid beta-oxidation (GO:0006635) | 2.92784332 |
| 120 | high-density lipoprotein particle remodeling (GO:0034375) | 2.92608489 |
| 121 | nucleoside salvage (GO:0043174) | 2.92438289 |
| 122 | cellular response to virus (GO:0098586) | 2.90733261 |
| 123 | melanin metabolic process (GO:0006582) | 2.89031432 |
| 124 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.89012012 |
| 125 | fatty acid oxidation (GO:0019395) | 2.88821913 |
| 126 | aromatic amino acid family metabolic process (GO:0009072) | 2.87376587 |
| 127 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.86800819 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 2.86496371 |
| 129 | lipid oxidation (GO:0034440) | 2.86211428 |
| 130 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.86163454 |
| 131 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.86163454 |
| 132 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.86163454 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 2.83687789 |
| 134 | regulation of complement activation (GO:0030449) | 2.83575754 |
| 135 | bile acid metabolic process (GO:0008206) | 2.81825026 |
| 136 | RNA modification (GO:0009451) | 2.81144543 |
| 137 | regulation of triglyceride catabolic process (GO:0010896) | 2.80370067 |
| 138 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.80135950 |
| 139 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.80135950 |
| 140 | exogenous drug catabolic process (GO:0042738) | 2.79604826 |
| 141 | nitrogen cycle metabolic process (GO:0071941) | 2.78933430 |
| 142 | flavonoid metabolic process (GO:0009812) | 2.77736076 |
| 143 | regulation of protein kinase A signaling (GO:0010738) | 2.77400865 |
| 144 | cofactor catabolic process (GO:0051187) | 2.77286305 |
| 145 | estrogen biosynthetic process (GO:0006703) | 2.76730748 |
| 146 | lipoprotein metabolic process (GO:0042157) | 2.76542248 |
| 147 | regulation of cholesterol metabolic process (GO:0090181) | 2.76513795 |
| 148 | RNA methylation (GO:0001510) | 2.76214772 |
| 149 | 4-hydroxyproline metabolic process (GO:0019471) | 2.75699796 |
| 150 | grooming behavior (GO:0007625) | 2.75136487 |
| 151 | phosphate ion homeostasis (GO:0055062) | 2.74198407 |
| 152 | trivalent inorganic anion homeostasis (GO:0072506) | 2.74198407 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74020374 |
| 154 | pentose-phosphate shunt (GO:0006098) | 2.73911463 |
| 155 | regulation of cholesterol esterification (GO:0010872) | 2.73180540 |
| 156 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.72688049 |
| 157 | NADP metabolic process (GO:0006739) | 2.71416557 |
| 158 | organic cation transport (GO:0015695) | 2.70530378 |
| 159 | negative regulation of fibrinolysis (GO:0051918) | 2.70457998 |
| 160 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.70403907 |
| 161 | fatty acid catabolic process (GO:0009062) | 2.69848311 |
| 162 | cardiolipin metabolic process (GO:0032048) | 2.69187872 |
| 163 | regulation of cholesterol storage (GO:0010885) | 2.69109180 |
| 164 | phospholipid efflux (GO:0033700) | 2.67650601 |
| 165 | ketone body metabolic process (GO:1902224) | 2.67439139 |
| 166 | sex determination (GO:0007530) | 2.67421728 |
| 167 | positive regulation of protein homooligomerization (GO:0032464) | 2.66458320 |
| 168 | cellular anion homeostasis (GO:0030002) | 2.66056845 |
| 169 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65000988 |
| 170 | renal absorption (GO:0070293) | 2.64898259 |
| 171 | alpha-amino acid catabolic process (GO:1901606) | 2.64826701 |
| 172 | cellular amino acid catabolic process (GO:0009063) | 2.64093383 |
| 173 | type B pancreatic cell proliferation (GO:0044342) | 2.63833198 |
| 174 | NADPH regeneration (GO:0006740) | 2.61986548 |
| 175 | tyrosine metabolic process (GO:0006570) | 2.61606090 |
| 176 | serine family amino acid biosynthetic process (GO:0009070) | 2.61571149 |
| 177 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.60485362 |
| 178 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.60485362 |
| 179 | monocarboxylic acid catabolic process (GO:0072329) | 2.60044631 |
| 180 | response to peptidoglycan (GO:0032494) | 2.59707391 |
| 181 | fructose metabolic process (GO:0006000) | 2.59289102 |
| 182 | reverse cholesterol transport (GO:0043691) | 2.58990591 |
| 183 | bile acid and bile salt transport (GO:0015721) | 2.58350951 |
| 184 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.57928377 |
| 185 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.57910733 |
| 186 | peptide catabolic process (GO:0043171) | 2.57798225 |
| 187 | carboxylic acid catabolic process (GO:0046395) | 2.56216034 |
| 188 | organic acid catabolic process (GO:0016054) | 2.56216034 |
| 189 | coenzyme catabolic process (GO:0009109) | 2.55617594 |
| 190 | regulated secretory pathway (GO:0045055) | 2.55442813 |
| 191 | negative regulation of cholesterol transport (GO:0032375) | 2.55279114 |
| 192 | negative regulation of sterol transport (GO:0032372) | 2.55279114 |
| 193 | sphingoid metabolic process (GO:0046519) | 2.55015505 |
| 194 | gonadal mesoderm development (GO:0007506) | 2.54649399 |
| 195 | keratan sulfate metabolic process (GO:0042339) | 2.54527455 |
| 196 | plasma lipoprotein particle assembly (GO:0034377) | 2.54337681 |
| 197 | cornea development in camera-type eye (GO:0061303) | 2.53558097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.84217870 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20930219 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.96560116 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.33832209 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18245400 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06890826 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.96668947 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87266515 |
| 9 | P68_20966046_ChIP-Seq_HELA_Human | 2.51307329 |
| 10 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.46836942 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.38271156 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.36858217 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.32542784 |
| 14 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.25111453 |
| 15 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21139148 |
| 16 | MAF_26560356_Chip-Seq_TH2_Human | 2.17567950 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16768032 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14432531 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.14309588 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99024497 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94488288 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89047400 |
| 23 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.85496665 |
| 24 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.81212112 |
| 25 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.77404193 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72682938 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72391175 |
| 28 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71429933 |
| 29 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.69917862 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68321537 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64328929 |
| 32 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.63943218 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62166826 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.61992565 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.61351371 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59654418 |
| 37 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.57337843 |
| 38 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.56622698 |
| 39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56445191 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56079629 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55593662 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54844031 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54208145 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53489827 |
| 45 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.52795532 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52077880 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52073696 |
| 48 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.51491840 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.50510828 |
| 50 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.50343757 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49744063 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49293168 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46936102 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46284448 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46256725 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45909588 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44540301 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43916233 |
| 59 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.43508525 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42626096 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42060019 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41452866 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40085696 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39255284 |
| 65 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38854408 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38716164 |
| 67 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38234621 |
| 68 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.37740780 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36455797 |
| 70 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35299715 |
| 71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33512459 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32496010 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31431071 |
| 74 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.31355794 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31012333 |
| 76 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.30599377 |
| 77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30481286 |
| 78 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30390431 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.29802169 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29507409 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28907329 |
| 82 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28808692 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27641720 |
| 84 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27574313 |
| 85 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26957353 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26852545 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25660566 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25205121 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25051405 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.23912637 |
| 91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22852588 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22322341 |
| 93 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21492626 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21015250 |
| 95 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20829294 |
| 96 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20708604 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20116113 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19642981 |
| 99 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17421981 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17172576 |
| 101 | * FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.16940424 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16870824 |
| 103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16863375 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16446291 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16266942 |
| 106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16262130 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16225497 |
| 108 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15484059 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14841869 |
| 110 | ERA_21632823_ChIP-Seq_H3396_Human | 1.13538974 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13440221 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12850621 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12477194 |
| 114 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11078853 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10706280 |
| 116 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.10618250 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08988255 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08531209 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08194761 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08169020 |
| 121 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07734440 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06999921 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06873233 |
| 124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06859609 |
| 125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06761994 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 1.06641094 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06505951 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05878200 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05772609 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04702534 |
| 131 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.04606272 |
| 132 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04002949 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02765313 |
| 134 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02118867 |
| 135 | P300_27268052_Chip-Seq_Bcells_Human | 1.01705707 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01327224 |
| 137 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99311538 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98748107 |
| 139 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98012039 |
| 140 | MYC_22102868_ChIP-Seq_BL_Human | 0.97914896 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96773352 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96613489 |
| 143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96483497 |
| 144 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95332777 |
| 145 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94908601 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94276208 |
| 147 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94071702 |
| 148 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93843451 |
| 149 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.92742604 |
| 150 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91869409 |
| 151 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91741989 |
| 152 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91075791 |
| 153 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.88795474 |
| 154 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88481608 |
| 155 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88251190 |
| 156 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87509535 |
| 157 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87429831 |
| 158 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87123487 |
| 159 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86868098 |
| 160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85976182 |
| 161 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.85647075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 5.81305491 |
| 2 | MP0005171_absent_coat_pigmentation | 5.72733314 |
| 3 | MP0005174_abnormal_tail_pigmentation | 4.88637769 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.69146690 |
| 5 | MP0003136_yellow_coat_color | 4.68179695 |
| 6 | MP0005360_urolithiasis | 4.45894951 |
| 7 | MP0005423_abnormal_somatic_nervous | 4.35236293 |
| 8 | MP0005365_abnormal_bile_salt | 3.35687311 |
| 9 | MP0009840_abnormal_foam_cell | 3.16121621 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07761457 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.01650172 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.91329589 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.75163548 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.57619157 |
| 15 | MP0001188_hyperpigmentation | 2.46077062 |
| 16 | MP0005083_abnormal_biliary_tract | 2.40296894 |
| 17 | MP0003252_abnormal_bile_duct | 2.39136976 |
| 18 | MP0001661_extended_life_span | 2.31168353 |
| 19 | MP0005409_darkened_coat_color | 2.28960456 |
| 20 | MP0005332_abnormal_amino_acid | 2.21369559 |
| 21 | MP0003436_decreased_susceptibility_to | 2.18271349 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 2.15032489 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.13876895 |
| 24 | MP0000750_abnormal_muscle_regeneration | 2.09294922 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.07310885 |
| 26 | MP0003195_calcinosis | 2.06818107 |
| 27 | MP0000015_abnormal_ear_pigmentation | 2.06091342 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.92478222 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.88241652 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.88087706 |
| 31 | MP0004381_abnormal_hair_follicle | 1.86374844 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.78980209 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.77756217 |
| 34 | MP0000685_abnormal_immune_system | 1.76498764 |
| 35 | MP0003186_abnormal_redox_activity | 1.75233443 |
| 36 | MP0009785_altered_susceptibility_to | 1.69633806 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.68582367 |
| 38 | MP0000609_abnormal_liver_physiology | 1.65910868 |
| 39 | MP0006082_CNS_inflammation | 1.65094992 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.64812861 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.64677393 |
| 42 | MP0000751_myopathy | 1.60908463 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.60821917 |
| 44 | MP0003724_increased_susceptibility_to | 1.60436039 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.56841583 |
| 46 | MP0005330_cardiomyopathy | 1.54373146 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.53435056 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.49556825 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.48440550 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.47240243 |
| 51 | MP0003303_peritoneal_inflammation | 1.46366239 |
| 52 | MP0005501_abnormal_skin_physiology | 1.44449841 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.43610648 |
| 54 | MP0008469_abnormal_protein_level | 1.43467804 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.40349649 |
| 56 | MP0002419_abnormal_innate_immunity | 1.39946284 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.39907570 |
| 58 | MP0002160_abnormal_reproductive_system | 1.38853377 |
| 59 | MP0000538_abnormal_urinary_bladder | 1.37341327 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.36250940 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.35640877 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.35527607 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.35006897 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.31536592 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30404707 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.26797895 |
| 67 | MP0005025_abnormal_response_to | 1.26131116 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.25659002 |
| 69 | MP0004130_abnormal_muscle_cell | 1.24704157 |
| 70 | MP0009278_abnormal_bone_marrow | 1.22239169 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.22151905 |
| 72 | MP0001756_abnormal_urination | 1.21514691 |
| 73 | MP0004947_skin_inflammation | 1.16948248 |
| 74 | MP0002136_abnormal_kidney_physiology | 1.14639637 |
| 75 | MP0002933_joint_inflammation | 1.13524736 |
| 76 | MP0000604_amyloidosis | 1.12318356 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.11333763 |
| 78 | MP0001764_abnormal_homeostasis | 1.10668004 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.09243109 |
| 80 | MP0003077_abnormal_cell_cycle | 1.08109043 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.07867841 |
| 82 | MP0000598_abnormal_liver_morphology | 1.06702759 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 1.05880301 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 1.05859659 |
| 85 | MP0005000_abnormal_immune_tolerance | 1.05202267 |
| 86 | MP0000858_altered_metastatic_potential | 1.04250787 |
| 87 | MP0001790_abnormal_immune_system | 1.03489052 |
| 88 | MP0005387_immune_system_phenotype | 1.03489052 |
| 89 | MP0003448_altered_tumor_morphology | 1.02778523 |
| 90 | MP0009764_decreased_sensitivity_to | 1.02465349 |
| 91 | MP0005670_abnormal_white_adipose | 1.02345427 |
| 92 | MP0001873_stomach_inflammation | 1.01394120 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 1.00066518 |
| 94 | MP0003868_abnormal_feces_composition | 0.97757723 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.96360096 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.92700188 |
| 97 | MP0003878_abnormal_ear_physiology | 0.92567360 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.92567360 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.92558740 |
| 100 | MP0004043_abnormal_pH_regulation | 0.91814893 |
| 101 | MP0005451_abnormal_body_composition | 0.91456060 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.91440797 |
| 103 | MP0002148_abnormal_hypersensitivity_rea | 0.91262605 |
| 104 | MP0001800_abnormal_humoral_immune | 0.91222075 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.90543879 |
| 106 | MP0005023_abnormal_wound_healing | 0.90469079 |
| 107 | MP0003075_altered_response_to | 0.90095723 |
| 108 | MP0002736_abnormal_nociception_after | 0.89809464 |
| 109 | MP0009763_increased_sensitivity_to | 0.89535534 |
| 110 | MP0009931_abnormal_skin_appearance | 0.89095258 |
| 111 | MP0003011_delayed_dark_adaptation | 0.88916551 |
| 112 | MP0002254_reproductive_system_inflammat | 0.88503777 |
| 113 | MP0002723_abnormal_immune_serum | 0.88413283 |
| 114 | MP0000470_abnormal_stomach_morphology | 0.88224439 |
| 115 | * MP0009642_abnormal_blood_homeostasis | 0.87903846 |
| 116 | MP0006054_spinal_hemorrhage | 0.86785528 |
| 117 | MP0001919_abnormal_reproductive_system | 0.84764235 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.81578385 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.80164890 |
| 120 | MP0002132_abnormal_respiratory_system | 0.79776644 |
| 121 | MP0000747_muscle_weakness | 0.79621038 |
| 122 | MP0003279_aneurysm | 0.79372916 |
| 123 | MP0005166_decreased_susceptibility_to | 0.77149699 |
| 124 | MP0002405_respiratory_system_inflammati | 0.76646340 |
| 125 | MP0009333_abnormal_splenocyte_physiolog | 0.76178283 |
| 126 | MP0005671_abnormal_response_to | 0.75111415 |
| 127 | MP0000343_altered_response_to | 0.74759029 |
| 128 | MP0001819_abnormal_immune_cell | 0.74678334 |
| 129 | MP0001853_heart_inflammation | 0.74356202 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.74256051 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.74256051 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.73876554 |
| 133 | MP0000367_abnormal_coat/_hair | 0.72626094 |
| 134 | MP0002928_abnormal_bile_duct | 0.71667696 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.70563319 |
| 136 | MP0002078_abnormal_glucose_homeostasis | 0.70535251 |
| 137 | MP0005410_abnormal_fertilization | 0.68997588 |
| 138 | MP0000358_abnormal_cell_content/ | 0.68996218 |
| 139 | MP0005375_adipose_tissue_phenotype | 0.68838493 |
| 140 | MP0001664_abnormal_digestion | 0.68363916 |
| 141 | MP0002135_abnormal_kidney_morphology | 0.68203979 |
| 142 | MP0008260_abnormal_autophagy | 0.68179271 |
| 143 | MP0001663_abnormal_digestive_system | 0.66958812 |
| 144 | MP0000689_abnormal_spleen_morphology | 0.66383272 |
| 145 | MP0001542_abnormal_bone_strength | 0.65678747 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.65344399 |
| 147 | MP0005389_reproductive_system_phenotype | 0.63358612 |
| 148 | * MP0002429_abnormal_blood_cell | 0.62180055 |
| 149 | MP0000678_abnormal_parathyroid_gland | 0.59656645 |
| 150 | MP0008874_decreased_physiological_sensi | 0.58712315 |
| 151 | MP0010094_abnormal_chromosome_stability | 0.58011922 |
| 152 | MP0000313_abnormal_cell_death | 0.56602560 |
| 153 | MP0010771_integument_phenotype | 0.55939281 |
| 154 | MP0001191_abnormal_skin_condition | 0.55183884 |
| 155 | MP0006036_abnormal_mitochondrial_physio | 0.55087046 |
| 156 | MP0001958_emphysema | 0.53500952 |
| 157 | MP0001905_abnormal_dopamine_level | 0.53446808 |
| 158 | MP0000716_abnormal_immune_system | 0.53069468 |
| 159 | MP0002735_abnormal_chemical_nociception | 0.52838996 |
| 160 | MP0006035_abnormal_mitochondrial_morpho | 0.51500659 |
| 161 | MP0002075_abnormal_coat/hair_pigmentati | 0.51442652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 6.29307159 |
| 2 | Rib fusion (HP:0000902) | 5.52623005 |
| 3 | Poikiloderma (HP:0001029) | 5.38159723 |
| 4 | Rectovaginal fistula (HP:0000143) | 5.04256863 |
| 5 | Rectal fistula (HP:0100590) | 5.04256863 |
| 6 | Vaginal fistula (HP:0004320) | 5.00931984 |
| 7 | Intestinal fistula (HP:0100819) | 4.76870619 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.63962317 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 4.55047057 |
| 10 | Dyschromatopsia (HP:0007641) | 4.54606119 |
| 11 | Ulnar bowing (HP:0003031) | 4.52262556 |
| 12 | Thin bony cortex (HP:0002753) | 4.36866919 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.03177178 |
| 14 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.00923764 |
| 15 | Annular pancreas (HP:0001734) | 3.96508374 |
| 16 | Xanthomatosis (HP:0000991) | 3.90768078 |
| 17 | Facial diplegia (HP:0001349) | 3.83723937 |
| 18 | Turricephaly (HP:0000262) | 3.80722524 |
| 19 | Akinesia (HP:0002304) | 3.72549255 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.69645430 |
| 21 | Popliteal pterygium (HP:0009756) | 3.68615903 |
| 22 | Squamous cell carcinoma (HP:0002860) | 3.63473922 |
| 23 | Aplasia of the musculature (HP:0100854) | 3.58981780 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.56997176 |
| 25 | Mesangial abnormality (HP:0001966) | 3.55504109 |
| 26 | Facial hemangioma (HP:0000329) | 3.50570429 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.48481111 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 3.48436881 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.46921019 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.42362241 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.42362241 |
| 32 | Congenital stationary night blindness (HP:0007642) | 3.40024588 |
| 33 | Delayed epiphyseal ossification (HP:0002663) | 3.36219035 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.34486652 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.33360953 |
| 36 | Flat acetabular roof (HP:0003180) | 3.26650722 |
| 37 | Deep venous thrombosis (HP:0002625) | 3.24590971 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.22881575 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.21618578 |
| 40 | Coronal craniosynostosis (HP:0004440) | 3.21078707 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18970347 |
| 42 | Renal Fanconi syndrome (HP:0001994) | 3.12913381 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.11921951 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.11921951 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.11921951 |
| 46 | Abnormal albumin level (HP:0012116) | 3.09352257 |
| 47 | Hypoalbuminemia (HP:0003073) | 3.09352257 |
| 48 | Anteriorly placed anus (HP:0001545) | 3.06427991 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.03595440 |
| 50 | Eczematoid dermatitis (HP:0000976) | 3.01300107 |
| 51 | Abnormality of the costochondral junction (HP:0000919) | 2.98688608 |
| 52 | Fetal akinesia sequence (HP:0001989) | 2.98325994 |
| 53 | Protuberant abdomen (HP:0001538) | 2.94920506 |
| 54 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.94302679 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.90467548 |
| 56 | Patellar aplasia (HP:0006443) | 2.90434928 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.90428800 |
| 58 | Complement deficiency (HP:0004431) | 2.88593142 |
| 59 | Joint stiffness (HP:0001387) | 2.84561597 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.82383703 |
| 61 | Short chin (HP:0000331) | 2.78505250 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.75778062 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.73846619 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73657453 |
| 65 | Amniotic constriction ring (HP:0009775) | 2.73131615 |
| 66 | Abnormality of placental membranes (HP:0011409) | 2.73131615 |
| 67 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.72790059 |
| 68 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.72508592 |
| 69 | Beaking of vertebral bodies (HP:0004568) | 2.71831038 |
| 70 | Absent thumb (HP:0009777) | 2.70689230 |
| 71 | Ketosis (HP:0001946) | 2.69558559 |
| 72 | Abnormality of complement system (HP:0005339) | 2.69484541 |
| 73 | Male infertility (HP:0003251) | 2.69412553 |
| 74 | Joint hemorrhage (HP:0005261) | 2.66385400 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.65742862 |
| 76 | Lipid accumulation in hepatocytes (HP:0006561) | 2.65595002 |
| 77 | Premature graying of hair (HP:0002216) | 2.65004562 |
| 78 | Polydipsia (HP:0001959) | 2.63971177 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.63971177 |
| 80 | Axonal loss (HP:0003447) | 2.62469542 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.61227253 |
| 82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.61172278 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.60514835 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.60444023 |
| 85 | Bowing of the arm (HP:0006488) | 2.59859123 |
| 86 | Bowed forearm bones (HP:0003956) | 2.59859123 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.58650272 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.57187227 |
| 89 | Myocardial infarction (HP:0001658) | 2.56420202 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.56042622 |
| 91 | Hypophosphatemic rickets (HP:0004912) | 2.55934433 |
| 92 | Hyperammonemia (HP:0001987) | 2.55187751 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51284369 |
| 94 | Choroideremia (HP:0001139) | 2.50690973 |
| 95 | Abnormality of macrophages (HP:0004311) | 2.49587104 |
| 96 | Increased muscle lipid content (HP:0009058) | 2.49567407 |
| 97 | Chorioretinal atrophy (HP:0000533) | 2.49278219 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48565002 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48565002 |
| 100 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48565002 |
| 101 | Decreased central vision (HP:0007663) | 2.48261257 |
| 102 | Gout (HP:0001997) | 2.44222527 |
| 103 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.44119463 |
| 104 | Atrioventricular block (HP:0001678) | 2.41700321 |
| 105 | Late onset (HP:0003584) | 2.41694558 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40614370 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 2.40614370 |
| 108 | Abdominal distention (HP:0003270) | 2.39150330 |
| 109 | Vertebral compression fractures (HP:0002953) | 2.35743515 |
| 110 | Glomerulonephritis (HP:0000099) | 2.35635040 |
| 111 | Myopathic facies (HP:0002058) | 2.33829771 |
| 112 | Hypolipoproteinemia (HP:0010981) | 2.33000004 |
| 113 | Ketoacidosis (HP:0001993) | 2.32871535 |
| 114 | Enlarged epiphyses (HP:0010580) | 2.32026464 |
| 115 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29049520 |
| 116 | Choanal stenosis (HP:0000452) | 2.28781293 |
| 117 | Widely patent fontanelles and sutures (HP:0004492) | 2.28067656 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 2.27970009 |
| 119 | Hydroxyprolinuria (HP:0003080) | 2.27970009 |
| 120 | Hyperbilirubinemia (HP:0002904) | 2.27047690 |
| 121 | Reduced antithrombin III activity (HP:0001976) | 2.26979267 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 2.26030692 |
| 123 | Flat occiput (HP:0005469) | 2.22761538 |
| 124 | Basal cell carcinoma (HP:0002671) | 2.22430372 |
| 125 | Malnutrition (HP:0004395) | 2.21332471 |
| 126 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.19573226 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17068729 |
| 128 | Hypoglycemic seizures (HP:0002173) | 2.16599474 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 2.15147862 |
| 130 | Abnormal trabecular bone morphology (HP:0100671) | 2.14997135 |
| 131 | Cheilitis (HP:0100825) | 2.14886469 |
| 132 | Zonular cataract (HP:0010920) | 2.14821734 |
| 133 | Pathologic fracture (HP:0002756) | 2.13672015 |
| 134 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.13340554 |
| 135 | Capillary hemangiomas (HP:0005306) | 2.12657944 |
| 136 | Respiratory difficulties (HP:0002880) | 2.10616237 |
| 137 | Hyperglycinuria (HP:0003108) | 2.09768202 |
| 138 | Neonatal onset (HP:0003623) | 2.07646525 |
| 139 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06775391 |
| 140 | Fat malabsorption (HP:0002630) | 2.06106941 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 2.06103861 |
| 142 | Abnormal epiphyseal ossification (HP:0010656) | 2.05947391 |
| 143 | Thoracic kyphosis (HP:0002942) | 2.04708761 |
| 144 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04697743 |
| 145 | Nasal polyposis (HP:0100582) | 2.03589650 |
| 146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02343073 |
| 147 | Birth length less than 3rd percentile (HP:0003561) | 2.01781543 |
| 148 | Hypercholesterolemia (HP:0003124) | 2.01709287 |
| 149 | Proximal tubulopathy (HP:0000114) | 2.01643946 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 2.01355095 |
| 151 | Petechiae (HP:0000967) | 1.99788129 |
| 152 | Nausea (HP:0002018) | 1.97176194 |
| 153 | Abnormality of the nasal mucosa (HP:0000433) | 1.95276898 |
| 154 | Cervical subluxation (HP:0003308) | 1.94569301 |
| 155 | Cupped ribs (HP:0000887) | 1.94488574 |
| 156 | Breast hypoplasia (HP:0003187) | 1.93865634 |
| 157 | Loss of speech (HP:0002371) | 1.93626236 |
| 158 | Tetraparesis (HP:0002273) | 1.93361320 |
| 159 | Ovoid vertebral bodies (HP:0003300) | 1.92451426 |
| 160 | Irritability (HP:0000737) | 1.92421182 |
| 161 | Exertional dyspnea (HP:0002875) | 1.91483939 |
| 162 | Symptomatic seizures (HP:0011145) | 1.91179061 |
| 163 | Abnormal platelet function (HP:0011869) | 1.91119118 |
| 164 | Impaired platelet aggregation (HP:0003540) | 1.91119118 |
| 165 | Opisthotonus (HP:0002179) | 1.90993246 |
| 166 | Mitral stenosis (HP:0001718) | 1.90491511 |
| 167 | Diminished movement (HP:0002374) | 1.90190469 |
| 168 | Gingival bleeding (HP:0000225) | 1.89063479 |
| 169 | Vascular calcification (HP:0004934) | 1.88604147 |
| 170 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87588132 |
| 171 | Increased serum ferritin (HP:0003281) | 1.87332411 |
| 172 | Short humerus (HP:0005792) | 1.87041745 |
| 173 | J-shaped sella turcica (HP:0002680) | 1.85581241 |
| 174 | Polyuria (HP:0000103) | 1.84604317 |
| 175 | Progressive muscle weakness (HP:0003323) | 1.83522475 |
| 176 | Abnormality of glycine metabolism (HP:0010895) | 1.83411059 |
| 177 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.83411059 |
| 178 | Thoracolumbar scoliosis (HP:0002944) | 1.82621830 |
| 179 | Interstitial pulmonary disease (HP:0006530) | 1.82527887 |
| 180 | Neonatal respiratory distress (HP:0002643) | 1.82131748 |
| 181 | Abnormal number of erythroid precursors (HP:0012131) | 1.81793219 |
| 182 | Pustule (HP:0200039) | 1.80861832 |
| 183 | Villous atrophy (HP:0011473) | 1.76334311 |
| 184 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.76334311 |
| 185 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.74860849 |
| 186 | Abnormality of renal resorption (HP:0011038) | 1.73908549 |
| 187 | Hypoplasia of the radius (HP:0002984) | 1.72212174 |
| 188 | Absent radius (HP:0003974) | 1.71301271 |
| 189 | Epiphyseal stippling (HP:0010655) | 1.71187291 |
| 190 | Increased number of teeth (HP:0011069) | 1.70928714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.68084666 |
| 2 | TLK1 | 3.82528900 |
| 3 | TRIB3 | 3.35175735 |
| 4 | BCKDK | 3.10148536 |
| 5 | FLT3 | 2.70602172 |
| 6 | ZAK | 2.61407764 |
| 7 | TESK1 | 2.52243568 |
| 8 | NME2 | 2.38857354 |
| 9 | PKN2 | 2.30519525 |
| 10 | SMG1 | 2.15980906 |
| 11 | SIK1 | 2.12462086 |
| 12 | STK16 | 2.08293955 |
| 13 | PIK3CG | 1.97240762 |
| 14 | MAPK15 | 1.96024341 |
| 15 | TBK1 | 1.95565418 |
| 16 | PIM2 | 1.93368838 |
| 17 | FGFR4 | 1.90603515 |
| 18 | KIT | 1.87723944 |
| 19 | ZAP70 | 1.85442546 |
| 20 | TAOK3 | 1.84379522 |
| 21 | MUSK | 1.80845059 |
| 22 | TGFBR2 | 1.70540282 |
| 23 | TESK2 | 1.65884361 |
| 24 | MAP4K1 | 1.60335908 |
| 25 | TYK2 | 1.57249341 |
| 26 | MAP3K3 | 1.53491527 |
| 27 | BLK | 1.50786871 |
| 28 | MAP2K3 | 1.50346440 |
| 29 | LRRK2 | 1.49916217 |
| 30 | MAP2K2 | 1.45118537 |
| 31 | KDR | 1.42903152 |
| 32 | PRKG2 | 1.41582017 |
| 33 | BTK | 1.38434225 |
| 34 | ACVR1B | 1.33700720 |
| 35 | EPHB1 | 1.31891268 |
| 36 | CSF1R | 1.31444071 |
| 37 | SIK2 | 1.28993107 |
| 38 | PTK6 | 1.27835831 |
| 39 | PAK4 | 1.27010263 |
| 40 | ARAF | 1.24117436 |
| 41 | DYRK1B | 1.22296473 |
| 42 | PBK | 1.19152516 |
| 43 | ICK | 1.16250349 |
| 44 | ABL2 | 1.13341515 |
| 45 | JAK3 | 1.12848298 |
| 46 | NEK9 | 1.11999215 |
| 47 | MAP3K10 | 1.11705998 |
| 48 | MAP3K11 | 1.11668566 |
| 49 | VRK2 | 1.09909999 |
| 50 | MAPKAPK3 | 1.08776711 |
| 51 | NEK2 | 1.08033764 |
| 52 | STK10 | 1.06637524 |
| 53 | IRAK2 | 1.05588734 |
| 54 | CDK4 | 1.03939352 |
| 55 | CDK12 | 0.99970645 |
| 56 | AURKA | 0.99379654 |
| 57 | IKBKB | 0.98987643 |
| 58 | SCYL2 | 0.92638254 |
| 59 | EPHA3 | 0.92479185 |
| 60 | MATK | 0.92076234 |
| 61 | PRKD2 | 0.92050285 |
| 62 | INSRR | 0.91075304 |
| 63 | IRAK3 | 0.89173818 |
| 64 | JAK1 | 0.86149684 |
| 65 | WNK4 | 0.85836570 |
| 66 | MYLK | 0.83428807 |
| 67 | EPHA2 | 0.83317569 |
| 68 | CCNB1 | 0.82937405 |
| 69 | GRK6 | 0.82359564 |
| 70 | MAP3K14 | 0.82171302 |
| 71 | MST1R | 0.80731956 |
| 72 | IRAK4 | 0.80678393 |
| 73 | ADRBK1 | 0.77871081 |
| 74 | RPS6KA4 | 0.76959540 |
| 75 | JAK2 | 0.76891291 |
| 76 | RPS6KC1 | 0.76595691 |
| 77 | RPS6KL1 | 0.76595691 |
| 78 | MELK | 0.75993037 |
| 79 | RPS6KA6 | 0.75810170 |
| 80 | TAOK2 | 0.73458480 |
| 81 | PTK2 | 0.71474400 |
| 82 | WNK3 | 0.69001920 |
| 83 | CSK | 0.67774729 |
| 84 | RIPK1 | 0.67354302 |
| 85 | PAK1 | 0.64572731 |
| 86 | RPS6KA2 | 0.64411941 |
| 87 | TTN | 0.63944696 |
| 88 | RPS6KA5 | 0.62975049 |
| 89 | MAPK11 | 0.62540378 |
| 90 | PIM1 | 0.61165611 |
| 91 | DDR2 | 0.59474847 |
| 92 | SYK | 0.59262517 |
| 93 | PRKD1 | 0.59039872 |
| 94 | MAPKAPK2 | 0.57852701 |
| 95 | MAP3K1 | 0.57730745 |
| 96 | CHEK2 | 0.57207316 |
| 97 | IRAK1 | 0.57164609 |
| 98 | TAOK1 | 0.56839991 |
| 99 | BRSK2 | 0.56644406 |
| 100 | IKBKE | 0.56292930 |
| 101 | LYN | 0.55859847 |
| 102 | DAPK3 | 0.55755718 |
| 103 | DYRK3 | 0.55067145 |
| 104 | MAPK12 | 0.53806720 |
| 105 | MAP2K6 | 0.53510050 |
| 106 | ADRBK2 | 0.52460649 |
| 107 | BUB1 | 0.50537757 |
| 108 | AKT2 | 0.50515623 |
| 109 | MAP3K8 | 0.48492462 |
| 110 | PRKCD | 0.48158112 |
| 111 | DAPK2 | 0.47796580 |
| 112 | RAF1 | 0.47422446 |
| 113 | MAPK4 | 0.47267811 |
| 114 | STK11 | 0.47171592 |
| 115 | EEF2K | 0.46942742 |
| 116 | MTOR | 0.46637086 |
| 117 | HCK | 0.46511018 |
| 118 | TGFBR1 | 0.46405194 |
| 119 | MET | 0.45347172 |
| 120 | LMTK2 | 0.45263569 |
| 121 | LCK | 0.45224604 |
| 122 | PDK2 | 0.45209273 |
| 123 | MAP2K1 | 0.45079727 |
| 124 | MARK3 | 0.44584249 |
| 125 | TEC | 0.44411025 |
| 126 | FRK | 0.44346122 |
| 127 | PAK2 | 0.43495101 |
| 128 | LIMK1 | 0.42144346 |
| 129 | TNK2 | 0.41962861 |
| 130 | CDK11A | 0.40887190 |
| 131 | PRPF4B | 0.40678308 |
| 132 | PDK4 | 0.40460844 |
| 133 | PDK3 | 0.40460844 |
| 134 | CHUK | 0.40039950 |
| 135 | ILK | 0.39544184 |
| 136 | CAMKK2 | 0.38688905 |
| 137 | PDPK1 | 0.38267881 |
| 138 | PLK1 | 0.37433391 |
| 139 | CDK15 | 0.36706341 |
| 140 | RPS6KB2 | 0.36172520 |
| 141 | BMX | 0.35332918 |
| 142 | GSK3A | 0.33786597 |
| 143 | PRKD3 | 0.33690853 |
| 144 | CDK6 | 0.33283912 |
| 145 | WNK1 | 0.31140794 |
| 146 | HIPK2 | 0.29488553 |
| 147 | CDK18 | 0.28986502 |
| 148 | RPS6KA1 | 0.28685039 |
| 149 | VRK1 | 0.26718467 |
| 150 | PRKCQ | 0.25518488 |
| 151 | PRKCI | 0.25064691 |
| 152 | PDK1 | 0.23885119 |
| 153 | CDK7 | 0.23582064 |
| 154 | BRAF | 0.22656112 |
| 155 | STK4 | 0.22537121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.63219509 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05377887 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.98305106 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.95308896 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.71840045 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.69631784 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44029492 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07021448 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.05713484 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99905071 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98208328 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.98090599 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96464887 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89684827 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.88489571 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87918284 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87377649 |
| 18 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.84958459 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84391968 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82565281 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79814384 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73615029 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.70404930 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69226414 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68465040 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67901657 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67216133 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65680092 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.63106819 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61820761 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61408694 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.60923082 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59323802 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58207950 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.57320381 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54670396 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50840392 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.50509370 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49847795 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49312232 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48232130 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42900151 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42103319 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42043694 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38522283 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38438731 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34718593 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34715270 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21888137 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19774044 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19058780 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18035114 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16723363 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15971640 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09986880 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09512862 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09327021 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.08635540 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.07807157 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06498067 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05886429 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04915182 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03393056 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98726836 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96924757 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.96368874 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95449740 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.94645654 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92553825 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91170165 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88983767 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88454969 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.88004514 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.86133204 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85490180 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83409246 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82977753 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80180449 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77307432 |
| 80 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77174018 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73085869 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69077435 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68873844 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.67903239 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66028513 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65008129 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.63855458 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.63468920 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.61471121 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58221608 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57387405 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56837063 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55390830 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.54428951 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52939580 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52321744 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50620024 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47880017 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.47536408 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46885923 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46075212 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45177000 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44562612 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.43204288 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42700035 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42580535 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42345927 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.42296810 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42127954 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41857068 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41567116 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41528395 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.41342564 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41063344 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41017439 |
| 116 | DNA replication_Homo sapiens_hsa03030 | 0.40609926 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40092702 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38687063 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37458957 |
| 120 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37270719 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.36118231 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35374963 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35279566 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34492187 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34082410 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.33316856 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33258907 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.32753522 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.32181553 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31889078 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.31046751 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.30962693 |
| 133 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30910000 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.30749034 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29888708 |
| 136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28668939 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28088192 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26836017 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25294206 |
| 140 | Cell cycle_Homo sapiens_hsa04110 | 0.25064987 |
| 141 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.25061475 |
| 142 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.24798799 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22680740 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22469389 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22112144 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.21269947 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19164190 |
| 148 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19034831 |
| 149 | Hepatitis B_Homo sapiens_hsa05161 | 0.18584129 |
| 150 | Influenza A_Homo sapiens_hsa05164 | 0.17915855 |
| 151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16726451 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16215300 |
| 153 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.15461748 |
| 154 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.15022358 |
| 155 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.14237129 |

